ASHLEY BAILES: Open Payments
NPI 1538790027 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 61 payments from 12 companies in 2025. Trend: 2023 $63 · 2024 $968 · 2025 $1,308
Food & beverage: $1,308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $261 |
| Lilly USA, LLC | 12 | $224 |
| AstraZeneca Pharmaceuticals LP | 10 | $199 |
| Dexcom, Inc. | 1 | $161 |
| ABBVIE INC. | 7 | $151 |
| Amgen Inc. | 6 | $113 |
| Exact Sciences Corporation | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Abbott Laboratories | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: MOUNJARO, DEXCOM G7 GSS (161), Wegovy, Ozempic, VRAYLAR, OTEZLA, Cologuard Collection Kit, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
